Compare LIN & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LIN | ABT |
|---|---|---|
| Founded | 1879 | 1888 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 217.0B | 222.8B |
| IPO Year | N/A | N/A |
| Metric | LIN | ABT |
|---|---|---|
| Price | $409.43 | $129.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 18 |
| Target Price | ★ $504.40 | $146.61 |
| AVG Volume (30 Days) | 2.9M | ★ 6.6M |
| Earning Date | 10-31-2025 | 10-15-2025 |
| Dividend Yield | 1.46% | ★ 1.83% |
| EPS Growth | 13.37 | ★ 141.97 |
| EPS | ★ 14.94 | 7.96 |
| Revenue | $33,504,000,000.00 | ★ $43,843,000,000.00 |
| Revenue This Year | $3.68 | $7.55 |
| Revenue Next Year | $5.54 | $7.70 |
| P/E Ratio | $27.46 | ★ $16.19 |
| Revenue Growth | 1.45 | ★ 6.37 |
| 52 Week Low | $406.09 | $110.86 |
| 52 Week High | $486.38 | $141.23 |
| Indicator | LIN | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 31.75 | 53.60 |
| Support Level | $406.09 | $126.23 |
| Resistance Level | $412.87 | $129.52 |
| Average True Range (ATR) | 6.44 | 2.72 |
| MACD | 0.30 | 0.31 |
| Stochastic Oscillator | 13.11 | 70.24 |
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $33 billion in revenue in 2024.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.